We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+43.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$538M
AUM Growth
+$55.9M
Cap. Flow
+$43.1M
Cap. Flow %
8.02%
Top 10 Hldgs %
29.12%
Holding
98
New
28
Increased
27
Reduced
19
Closed
23

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$11.2M
2
GPOR
Gulfport Energy Corp.
GPOR
+$11M
3
CAR icon
Avis
CAR
+$10.2M
4
MU icon
Micron Technology
MU
+$9.64M
5
JBGS
JBG SMITH
JBGS
+$9.05M

Sector Composition

Rank Sector Weight
1 Technology 16.65%
2 Healthcare 16.27%
3 Financials 13.33%
4 Consumer Discretionary 11.82%
5 Communication Services 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWS icon
51
iShares MSCI Singapore ETF
EWS
$1.16B
$4.73M 0.88%
+177,368
New +$4.78M
VWO icon
52
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$4.71M 0.88%
100,186
+189
+0.2% +$9.06K
EIDO icon
53
iShares MSCI Indonesia ETF
EIDO
$492M
$4.45M 0.83%
+165,017
New +$4.74M
EPHE icon
54
iShares MSCI Philippines ETF
EPHE
$148M
$4.44M 0.83%
+127,162
New +$4.73M
DXCM icon
55
DexCom
DXCM
$34.3B
$3.54M 0.66%
+190,672
New +$2.82M
ONC
56
BeOne Medicines Ltd
ONC
$40.6B
$3.49M 0.65%
20,796
-12,104
-37% -$1.64M
ASND icon
57
Ascendis Pharma A/S
ASND
$16.8B
$3.14M 0.58%
47,997
-25,774
-35% -$1.45M
ABMD
58
DELISTED
Abiomed Inc
ABMD
$3.04M 0.57%
10,453
-3,063
-23% -$776K
VNDA icon
59
Vanda Pharmaceuticals
VNDA
$314M
$2.88M 0.54%
170,834
-31,396
-16% -$526K
MDCO
60
DELISTED
Medicines Co
MDCO
$2.71M 0.5%
82,227
-229,839
-74% -$7.18M
HUM icon
61
Humana
HUM
$46.7B
$2.67M 0.5%
9,945
-987
-9% -$267K
WCG
62
DELISTED
Wellcare Health Plans, Inc.
WCG
$2.64M 0.49%
+13,626
New +$2.73M
ALNY icon
63
Alnylam Pharmaceuticals
ALNY
$30B
$2.64M 0.49%
22,130
+2,035
+10% +$262K
SGEN
64
DELISTED
Seagen Inc. Common Stock
SGEN
$2.57M 0.48%
49,099
+3,315
+7% +$181K
GHDX
65
DELISTED
Genomic Health, Inc.
GHDX
$2.53M 0.47%
80,903
-11,376
-12% -$377K
EPZM
66
DELISTED
Epizyme, Inc
EPZM
$2.46M 0.46%
138,431
-66,169
-32% -$1.12M
IMMU
67
DELISTED
Immunomedics Inc
IMMU
$2.44M 0.45%
+167,038
New +$2.73M
DVA icon
68
DaVita
DVA
$11.6B
$2.33M 0.43%
+35,345
New +$2.6M
CLVS
69
DELISTED
Clovis Oncology, Inc.
CLVS
$2.31M 0.43%
43,761
+3,772
+9% +$220K
DBVT
70
DBV Technologies
DBVT
$889M
$2.27M 0.42%
9,831
-1,681
-15% -$397K
UTHR icon
71
United Therapeutics
UTHR
$21.9B
$2.13M 0.4%
18,946
-3,139
-14% -$399K
ATRA icon
72
Atara Biotherapeutics
ATRA
$83.1M
$2.07M 0.39%
+2,126
New +$1.94M
INSM icon
73
Insmed
INSM
$28.9B
$2.04M 0.38%
90,753
+3,632
+4% +$95.6K
NGNE icon
74
Neurogene
NGNE
$738M
$1.94M 0.36%
6,893
-5,662
-45% -$1.56M
VNQ icon
75
Vanguard Real Estate ETF
VNQ
$38.6B
$1.22M 0.23%
16,206
+149
+0.9% +$11.4K

Similar funds

University of Notre Dame du Lac's Q1 2018 Portfolio in Review

As of Q1 2018, University of Notre Dame du Lac held 98 positions worth $538M, up 12% from $482M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

University of Notre Dame du Lac deployed $43.1M of net new capital in Q1 2018, opening 28 new positions and adding to 27 existing holdings. Its largest new stake was Labcorp: 76,429 shares worth $10.6M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Charter Communications, an estimated $13.9M trimmed.

  • University of Notre Dame du Lac's largest Q1 2018 buy was Labcorp: 76,429 shares worth $10.6M.
  • University of Notre Dame du Lac added most to Amazon in Q1 2018, an estimated $8.17M increase.
  • University of Notre Dame du Lac's biggest Q1 2018 reduction was Charter Communications, cutting an estimated $13.9M.
  • University of Notre Dame du Lac fully exited Twenty-First Century Fox, Inc. Class A in Q1 2018, selling an estimated $8.81M.
  • University of Notre Dame du Lac's ten largest holdings make up 29% of its $538M portfolio in Q1 2018.
  • University of Notre Dame du Lac opened 28 new positions and closed 23 in Q1 2018.
  • University of Notre Dame du Lac's portfolio value rose 12% quarter-over-quarter to $538M.

Based on University of Notre Dame du Lac's 13F filing for Q1 2018, filed 15 May 2018.